We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current KMSTF market cap is 23.31M. The company's latest EPS is ILS -0.3299 and P/E is -1.94.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.71M | -20.29M | -24.3M | -22.01M | -11.04M |
| Net Income | -25.09M | -21.71M | -26.28M | -22.72M | -12.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Total Assets | 7.29M | 10.79M | 27.34M | 12.49M | 8.37M |
| Total Liabilities | 19.32M | 18.85M | 11.96M | 12.16M | 12.73M |
| Total Equity | -12.03M | -8.06M | 15.38M | 326k | -4.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | ILS (ILS) | |
| Operating | -21.13M | -21.83M | -21.55M | -20M | -11.09M |
| Investing | -688k | -162k | -380k | -656k | 333k |
| Financing | 10.93M | 27.36M | 39.8M | 3.72M | 8.59M |
| Market Cap | 23.31M |
| Price to Earnings Ratio | -1.94 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.61 |
| Price to Book Ratio | -5.34 |
| Dividend Yield | - |
| Shares Outstanding | 36.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 0.00% |
| 52 Week High | 0.6404 |
| 52 Week Low | 0.6404 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Kadimastem Ltd (CE) |
| Address |
7 pinchas sapir ness ziona, center 74140 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
